Minapharm Pharmaceuticals
Manufacturing · Egypt · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
2t El Bardissi St, Cairo, Cairo, EgyptPhone Number
+20 224143170Website
www.minapharm.comRevenue
$80.7 MillionStock Symbol
MIPH.CAIndustry
About Minapharm Pharmaceuticals
Minapharm Pharmaceuticals Org Chart
Regional Manager, S Export
Manager
Manager, Business Unit
Manager, Production Minapharm
Validation Manager
Manager, Maintenance
Manager, Logistics
Deputy Manager, Business Unit
Manager, Operational & Supply Chain
Is Minapharm Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Minapharm Pharmaceuticals launches new products
Earning: See what the market has to say on Minapharm Pharmaceuticals recently announced quarterly report
Click to see if Minapharm Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Minapharm Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Minapharm Pharmaceuticals
Website visits: Recent activity has been detected on your website
Check if Minapharm Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Minapharm Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Minapharm Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Minapharm Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Minapharm Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Minapharm Pharmaceuticals.
Minapharm Pharmaceuticals Tech Stack
A closer look at the technologies used by Minapharm Pharmaceuticals
Most Recent Scoops
Minapharm Pharmaceuticals News & Media
Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®
CAIRO and PARIS, Dec. 10, 2023 /PRNewswire/ -- Sanofi and Minapharm announce the signing of an exclusive Manufacturing and Supply Agreement for the localization of the full range of its flagship market leader product, Clexane®. The agreement between Sanofi, a global pharmaceutical company...Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa
BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of an exclusive license...ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company
BERLIN and CAIRO, May 27, 2021 /PRNewswire/ -- ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGen's subsidiary "MiGenTra" with headquarters in Berlin and access to a site in Cairo, which will house its principal manufacturing plant. The formation of MiGenTra accelerates ProBioGen's 2030 growth roadmap and showcases that further growth is not limited to the ongoing capacity increase but reveals one of several significant steps in the diversification of ProBioGen's busRDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt
MOSCOW, CAIRO and BERLIN, April 22, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million doses per year of the world's first registered vaccine against COVID-19, Sputnik V. The parties intend to commence technology transfer immediately. The rollout of the vaccine is expected in 3Q 2021. RD
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Minapharm Pharmaceuticals
MINAPHARM is an Egyptian pharmaceutical company backed by more than fifty years of prominent existence in the local Egyptian pharmaceutical market. During the 50's, the first privately owned Factory in Egypt "Heliopolis Pharmaceutical Laboratories" was established. By the 60's, nationalization took place and MINAPHARM stopped its activity. During t... Read More